From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy - PubMed (original) (raw)
Review
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy
Liufu Deng et al. Clin Cancer Res. 2016.
Abstract
Local irradiation (IR) is widely used in the treatment of primary and metastatic tumors. However, the impact of IR on the immune response is currently being defined. Local and distant relapse after radiotherapy often occurs. The current rationale for the use of IR is based on direct cytotoxicity to cancer cells; however, recent studies have shown that reduction of tumor burden following ablative (large-dose) IR largely depends on type I IFN signaling and CD8(+) T-cell response. Here, we review recent findings indicating that antitumor effects of radiation are contributed by both innate and adaptive immune responses. We focus on immune mechanisms, including cytosolic DNA sensing pathways that bridge the traditional view of IR-mediated DNA damage to DNA-sensing immune pathways. Also, we discuss how the efficacy of radiotherapy might be enhanced by targeting nucleic acid-sensing pathways. These findings highlight the mechanisms governing tumor escape from the immune response and the therapeutic potential of synergistic strategies to improve the efficacy of radiotherapy via immunotherapeutic intervention.
©2015 American Association for Cancer Research.
Similar articles
- Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.
Iurescia S, Fioretti D, Rinaldi M. Iurescia S, et al. Front Immunol. 2018 Apr 9;9:711. doi: 10.3389/fimmu.2018.00711. eCollection 2018. Front Immunol. 2018. PMID: 29686682 Free PMC article. Review. - The immunological consequences of radiation-induced DNA damage.
Wilkins AC, Patin EC, Harrington KJ, Melcher AA. Wilkins AC, et al. J Pathol. 2019 Apr;247(5):606-614. doi: 10.1002/path.5232. Epub 2019 Feb 15. J Pathol. 2019. PMID: 30632153 Review. - Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
Iurescia S, Fioretti D, Rinaldi M. Iurescia S, et al. Recent Pat Anticancer Drug Discov. 2018;13(1):2-17. doi: 10.2174/1574892812666171030163804. Recent Pat Anticancer Drug Discov. 2018. PMID: 29086701 Review. - Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy.
Dar TB, Henson RM, Shiao SL. Dar TB, et al. Front Immunol. 2019 Jan 14;9:3077. doi: 10.3389/fimmu.2018.03077. eCollection 2018. Front Immunol. 2019. PMID: 30692991 Free PMC article. Review. - Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes.
Taffoni C, Steer A, Marines J, Chamma H, Vila IK, Laguette N. Taffoni C, et al. Front Immunol. 2021 Apr 26;12:660560. doi: 10.3389/fimmu.2021.660560. eCollection 2021. Front Immunol. 2021. PMID: 33981307 Free PMC article. Review.
Cited by
- Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response.
Savarin M, Kamensek U, Cemazar M, Heller R, Sersa G. Savarin M, et al. Radiol Oncol. 2017 Feb 22;51(1):30-39. doi: 10.1515/raon-2017-0011. eCollection 2017 Mar 1. Radiol Oncol. 2017. PMID: 28265230 Free PMC article. - Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy.
Lu S, Wang C, Ma J, Wang Y. Lu S, et al. Front Immunol. 2024 Sep 16;15:1456030. doi: 10.3389/fimmu.2024.1456030. eCollection 2024. Front Immunol. 2024. PMID: 39351241 Free PMC article. Review. - The Steroidal Alkaloid Tomatidine and Tomatidine-Rich Tomato Leaf Extract Suppress the Human Gastric Cancer-Derived 85As2 Cells In Vitro and In Vivo via Modulation of Interferon-Stimulated Genes.
Fujimaki J, Sayama N, Shiotani S, Suzuki T, Nonaka M, Uezono Y, Oyabu M, Kamei Y, Nukaya H, Wakabayashi K, Morita A, Sato T, Miura S. Fujimaki J, et al. Nutrients. 2022 Feb 28;14(5):1023. doi: 10.3390/nu14051023. Nutrients. 2022. PMID: 35267998 Free PMC article. - Radiotherapy to Control Limited Melanoma Progression Following Ipilimumab.
Kropp LM, De Los Santos JF, McKee SB, Conry RM. Kropp LM, et al. J Immunother. 2016 Nov/Dec;39(9):373-378. doi: 10.1097/CJI.0000000000000142. J Immunother. 2016. PMID: 27662339 Free PMC article. - Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.
Chen J, Cao Y, Markelc B, Kaeppler J, Vermeer JA, Muschel RJ. Chen J, et al. J Clin Invest. 2019 Oct 1;129(10):4224-4238. doi: 10.1172/JCI127458. J Clin Invest. 2019. PMID: 31483286 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials